Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. | Gut | 2020 | 32001555 | PubTator, text mining | PubMed |
| The Viral SUMO-Targeted Ubiquitin Ligase ICP0 is Phosphorylated and Activated by Host Kinase Chk2. | J Mol Biol | 2020 | 32001251 | PubTator, text mining | PubMed |
| Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4. | Mol Ther Oncolytics | 2020 | 31970286 | PubTator, text mining | PubMed |
| SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T. | Aging (Albany NY) | 2020 | 31969492 | PubTator, text mining | PubMed |
| Identification of osteosarcoma driver genes using a network method. | Oncol Lett | 2020 | 31966051 | PubTator, text mining | PubMed |
| Silencing of SENP2 in Multiple Myeloma Induces Bortezomib Resistance by Activating NF-κB Through the Modulation of IκBα Sumoylation. | Sci Rep | 2020 | 31964975 | PubTator, text mining | PubMed |
| Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators. | Int J Mol Sci | 2020 | 31936842 | PubTator, text mining | PubMed |
| Deep2Full: Evaluating strategies for selecting the minimal mutational experiments for optimal computational predictions of deep mutational scan outcomes. | PLoS One | 2020 | 31923916 | PubTator, text mining | PubMed |
| SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation. | FASEB J | 2020 | 31914638 | PubTator, text mining | PubMed |
| Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia. | Bioessays | 2020 | 31867767 | PubTator, text mining | PubMed |
| Formation of SUMO3-conjugated chains of MAVS induced by poly(dA:dT), a ligand of RIG-I, enhances the aggregation of MAVS that drives the secretion of interferon-β in human keratinocytes. | Biochem Biophys Res Commun | 2020 | 31806367 | PubTator, text mining | PubMed |
| Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. | Mol Psychiatry | 2020 | 31792364 | PubTator, text mining | PubMed |
| Chordate PIAS proteins act as conserved repressors of the TRAF6 self-polyubiquitination. | Dev Comp Immunol | 2020 | 31758961 | PubTator, text mining | PubMed |
| Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution. | Cell Mol Life Sci | 2020 | 31728578 | PubTator, text mining | PubMed |
| Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation. | Nucleic Acids Res | 2020 | 31722399 | PubTator, text mining | PubMed |
| Topoisomerase II SUMOylation activates a metaphase checkpoint via Haspin and Aurora B kinases. | J Cell Biol | 2020 | 31712254 | PubTator, text mining | PubMed |
| Phosphine-Activated Lysine Analogues for Fast Chemical Control of Protein Subcellular Localization and Protein SUMOylation. | Chembiochem | 2020 | 31664790 | PubTator, text mining | PubMed |
| Identification of key genes, regulatory factors, and drug target genes of recurrent implantation failure (RIF). | Gynecol Endocrinol | 2020 | 31646911 | PubTator, text mining | PubMed |
| Structural and Functional Analysis of Ubiquitin-based Inhibitors That Target the Backsides of E2 Enzymes. | J Mol Biol | 2020 | 31634471 | PubTator, text mining | PubMed |
| Post-translational modification of SOX family proteins: Key biochemical targets in cancer? | Semin Cancer Biol | 2020 | 31539559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=56